1,079 reports of this reaction
3.6% of all ISONIAZID reports
#2 most reported adverse reaction
PYREXIA is the #2 most commonly reported adverse reaction for ISONIAZID, manufactured by CMP Pharma, Inc.. There are 1,079 FDA adverse event reports linking ISONIAZID to PYREXIA. This represents approximately 3.6% of all 29,971 adverse event reports for this drug.
Patients taking ISONIAZID who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PYREXIA is moderately reported among ISONIAZID users, representing a notable but not dominant share of adverse events.
In addition to pyrexia, the following adverse reactions have been reported for ISONIAZID:
The following drugs have also been linked to pyrexia in FDA adverse event reports:
PYREXIA has been reported as an adverse event in 1,079 FDA reports for ISONIAZID. This does not prove causation, but indicates an association observed in post-market surveillance data.
PYREXIA accounts for approximately 3.6% of all adverse event reports for ISONIAZID, making it one of the most commonly reported side effect.
If you experience pyrexia while taking ISONIAZID, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.